Please find enclosed the Standalone Unaudited Financial results for the Quarter and Nine months ended 31st December, 2025 along with the Limited Review Report of the Statutory Auditors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMC Speciality Hospitals reported strong Q3 FY26 results with revenue from operations of Rs 8,206.03 lakhs, up about 33.7% from Rs 6,136.41 lakhs in Q3 FY25. For the nine months ended December 2025, revenue rose 31% YoY to Rs 22,351.51 lakhs versus Rs 17,066.28 lakhs last year. Profit after tax for Q3 jumped to Rs 1,372.78 lakhs (from Rs 751.38 lakhs, a ~83% increase), while nine-month PAT nearly doubled to Rs 3,210.10 lakhs from Rs 1,690.51 lakhs. Q3 EPS stood at Rs 0.84 versus Rs 0.46 in the year-ago quarter. Deloitte Haskins & Sells issued an unmodified limited review report with no qualifications or emphasis-of-matter observations.
Strong double-digit revenue growth and near-doubling of profits signal robust operational momentum, likely supportive of positive investor sentiment and a positive short-term stock reaction. The clean auditor review and absence of any flagged items further reinforce confidence in the reported numbers.